Connor, Clark & Lunn Investment Management (CC&L)’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-98,062	Closed	-$102K	–	1480
2022 Q3	$102K	Buy	+98,062	New	+$157K	﹤0.01%	1041
2022 Q1	–	Sell	-11,966	Closed	-$57K	–	1267
2021 Q4	$57K	Sell	11,966 -31,334	-72%	-$202K	﹤0.01%	1045
2021 Q3	$328K	Buy	+43,300	New	+$277K	﹤0.01%	852

Other funds holding SURF

AWA

Arete Wealth Advisors Chicago, Illinois $3.05B AUM 42.78% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s SURF Position: Q4 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Surface Oncology, Inc. Common Stock (SURF) in Q4 2022, closing a stake of 98,062 shares — an estimated $102K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SURF in Q3 2021 and held it in 3 quarters. The position peaked at $328K in Q3 2021. 79 funds tracked by Wall St. Rank hold SURF as of Q4 2022.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Surface Oncology, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 98,062 Surface Oncology, Inc. Common Stock shares in Q4 2022, an estimated $102K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Surface Oncology, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Surface Oncology, Inc. Common Stock position peaked at $328K in Q3 2021.
79 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q4 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2022, filed 10 Feb 2023.